Complete Filing Data
Moolec Science SA reported Research And Development Expense of $15.14 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Moolec Science SA did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Research And Development Expense | $15.1M | $17.4M | $15.9M | $985.2K |
| Profit Loss From Operating Activities | -$104.2M | $19.3M | $98.0M | -$3.7M |
| Profit Loss Before Tax | -$170.0M | -$28.0M | $50.8M | -$4.5M |
| Comprehensive Income | -$180.3M | -$30.2M | $50.7M | -$4.5M |
| Profit Loss | -$176.6M | -$29.1M | $53.1M | -$4.5M |
| Sales And Marketing Expense | $643.1K | $256.4K | $105.1K | |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Before Tax | -$4.5M | |||
| Cost Of Sales | $203.4M | $279.4M | $235.5M | |
| Income Tax Expense Continuing Operations | $6.6M | $1.1M | -$2.3M | |
| Adjustments For Income Tax Expense | $6.6M | $1.1M | -$2.3M | |
| Other Comprehensive Income | $107.6K | $18.1K | ||
| Amortization Of Intangible Asset | $11.2M | $12.1M | $11.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2020 |
|---|---|
| Research And Development Expense | $179.1K |
| Profit Loss From Operating Activities | -$320.5K |
| Profit Loss Before Tax | -$320.5K |
| Comprehensive Income | -$320.5K |
| Profit Loss | -$320.5K |
| Sales And Marketing Expense | $10.9K |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Before Tax | -$320.5K |
| Cost Of Sales | |
| Income Tax Expense Continuing Operations | |
| Adjustments For Income Tax Expense | |
| Other Comprehensive Income | |
| Amortization Of Intangible Asset |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents If Different From Statement Of Financial Position | $767.9K | $53.0M | $49.3M | $34.9M | $980.5K |
| Cash Flows From Used In Operating Activities | $3.6M | $39.6M | -$41.2M | -$1.9M | |
| Intangible Assets Other Than Goodwill | $75.3M | $177.3M | $175.3M | $4.6M | $4.6M |
| Cash Flows From Used In Financing Activities | -$15.0M | -$1.5M | $76.2M | $2.0M | |
| Cash And Cash Equivalents | $767.9K | $53.0M | $2.5M | $1.1M | |
| Trade And Other Current Payables | $7.3M | $168.9M | $7.5M | $1.2M | |
| Retained Earnings | -$110.3M | $1.1M | -$58.6M | -$6.8M | |
| Noncurrent Assets | $173.5M | $511.6M | $18.7M | $4.6M | |
| Liabilities | $287.6M | $699.8M | $13.9M | $4.1M | |
| Equity And Liabilities | $204.7M | $949.8M | $24.1M | $5.7M | |
| Current Liabilities | $236.1M | $427.4M | $12.6M | $4.1M | |
| Current Assets | $31.2M | $438.2M | $5.3M | $1.1M | |
| Assets | $204.7M | $949.8M | $24.1M | $5.7M | |
| Equity Settled Share Based Payment | $2.0M | $1.1M | $838.6K | ||
| Adjustments For Increase Decrease In Trade Account Payable | $2.5M | $1.5M | $926.7K | ||
| Other Current Liabilities | $1.5M | $1.7M | $1.2K | ||
| Fixed Assets | $1.2M | $1.1M | $8.9K | ||
| Equity Settled Share Based Payments | $3.4M | $1.3M | $838.6K | ||
| Adjustments For Decrease Increase In Trade And Other Receivables | $2.0M | -$6.3M | -$36.7M | ||
| Adjustments For Decrease Increase In Trade Account Receivable | $26.0M | -$41.3M | -$14.2M | ||
| Cash Flows From Used In Investing Activities | -$36.0M | -$27.4M | -$25.6M | ||
| Warrant Liability | $555.5K | $887.7K | |||
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $5.7M | $9.9M | $11.5M | ||
| Noncurrent Receivables | $10.1M | $8.8M | |||
| Gains Losses On Financial Assets At Fair Value Through Profit Or Loss | -$313.3K | -$860.0K | |||
| Rightofuse Assets | $100.9K | $11.6M | $43.8K | ||
| Other Receivables | $1.0M | $1.3M | |||
| Noncurrent Liabilities | $51.5M | $272.4M | $1.3M | ||
| Deferred Tax Liabilities | $15.8M | $34.5M | $1.1M | ||
| Current Trade Receivables | $6.1M | $209.0M | $361.1K | ||
| Goodwill | $112.2M | $251.4K | |||
| Purchase Of Intangible Assets Classified As Investing Activities | $350.8K | $3.2M | $688.3K | ||
| Other Current Financial Liabilities | $2.6M | $2.5M | |||
| Adjustments For Increase Decrease In Other Liabilities | -$263.2K | -$837.2K | -$1.2K | ||
| Other Noncurrent Financial Liabilities | $11.7M | $99.0K | |||
| Other Liabilitie | -$837.2K | -$1.2K | |||
| Other Noncurrent Payables | $196.5K | $175.3K | |||
| Depreciation Of Fixed Assets | $177.2K | $27.5K | $1.7K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2020 |
|---|---|
| Cash And Cash Equivalents If Different From Statement Of Financial Position | |
| Cash Flows From Used In Operating Activities | -$2.6M |
| Intangible Assets Other Than Goodwill | |
| Cash Flows From Used In Financing Activities | $2.6M |
| Cash And Cash Equivalents | |
| Trade And Other Current Payables | |
| Retained Earnings | |
| Noncurrent Assets | |
| Liabilities | |
| Equity And Liabilities | |
| Current Liabilities | |
| Current Assets | |
| Assets | |
| Equity Settled Share Based Payment | |
| Adjustments For Increase Decrease In Trade Account Payable | $19.6K |
| Other Current Liabilities | |
| Fixed Assets | |
| Equity Settled Share Based Payments | |
| Adjustments For Decrease Increase In Trade And Other Receivables | |
| Adjustments For Decrease Increase In Trade Account Receivable | -$2.3M |
| Cash Flows From Used In Investing Activities | |
| Warrant Liability | |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | |
| Noncurrent Receivables | |
| Gains Losses On Financial Assets At Fair Value Through Profit Or Loss | |
| Rightofuse Assets | |
| Other Receivables | |
| Noncurrent Liabilities | |
| Deferred Tax Liabilities | |
| Current Trade Receivables | |
| Goodwill | |
| Purchase Of Intangible Assets Classified As Investing Activities | |
| Other Current Financial Liabilities | |
| Adjustments For Increase Decrease In Other Liabilities | |
| Other Noncurrent Financial Liabilities | |
| Other Liabilitie | |
| Other Noncurrent Payables | |
| Depreciation Of Fixed Assets |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Increase Decrease In Cash And Cash Equivalents | -$47.4M | $10.7M | $9.5M | $114.0K |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | -$4.9M | -$6.7M | $5.1M | -$12.7K |
| Proceeds From Issuing Shares | 2.2M | 10.7K | ||
| Proceeds From Current Borrowings | $2.6M | $2.2M | ||
| Proceeds From Sales Or Maturity Of Financial Instruments Classified As Investing Activities | $437.7K | $2.3M | ||
| Effect Of Exchange Rate Changes And Inflation On Cash And Equivalents | $344.3K | $12.4K | -$12.7K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Diluted Earnings Loss Per Share | $-17.25 | $-5.61 | $8.80 | $-0.15 |
| Basic Earnings Loss Per Share | $-17.25 | $-5.61 | $8.80 | $-0.15 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2020 |
|---|---|
| Diluted Earnings Loss Per Share | $-0.01 |
| Basic Earnings Loss Per Share | $-0.01 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Other Operating Income Expense | -$56.6M | -$703.3K | $1.1M | -$39.0K | ||
| Share Premium | $69.2M | $67.0M | $7.3M | $7.3M | $4.3M | |
| Administrative Expense | $7.5M | $4.8M | $2.5M | |||
| Finance Income Cost | -$41.8M | -$37.6M | -$33.6M | -$14.5K | ||
| Adjustments For Sharebased Payments | $4.4M | $14.2M | $3.5M | $838.6K | ||
| Other Finance Income Cost | -$24.0M | -$9.6M | -$13.7M | -$872.3K | ||
| Issued Capital | $1.1M | $598.4K | $375.6K | $310.0K | ||
| Adjustments For Decrease Increase In Prepaid Expenses | $291.8K | $339.0K | $1.7K | |||
| Finance Costs | $1.2M | $160.0K | $2.1K | |||
| Inventories | $2.2M | $125.9M | $465.7K | |||
| Gains Losses On Exchange Differences On Translation Net Of Tax | -$2.9M | -$2.1M | -$865.4K | |||
| Current Prepayments | $596.9K | $341.1K | $2.1K | |||
| Reserve Of Exchange Differences On Translation | -$2.0M | $534.8K | $18.1K | |||
| Repayments Of Borrowings Classified As Financing Activities | $380.0M | $145.0M | $38.5M | |||
| Interest Paid Classified As Financing Activities | $28.1M | $36.8M | $25.6M | |||
| Adjustments For Decrease Increase In Inventories | $34.9M | $15.3M | -$8.6M | |||
| Adjustments For Depreciation And Amortisation Expense | $122.0K | $1.7K | ||||
| Issue Of Share Capital | $10.7K | |||||
| Reclassification Adjustments On Exchange Differences On Translation Net Of Tax | $107.6K | $18.1K | ||||
| Share To Be Issued Amount | $77.6K | $3.1K | $3.1K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2020 |
|---|---|
| Other Operating Income Expense | -$2.6K |
| Share Premium | |
| Administrative Expense | $127.9K |
| Finance Income Cost | |
| Adjustments For Sharebased Payments | |
| Other Finance Income Cost | |
| Issued Capital | |
| Adjustments For Decrease Increase In Prepaid Expenses | |
| Finance Costs | |
| Inventories | |
| Gains Losses On Exchange Differences On Translation Net Of Tax | |
| Current Prepayments | |
| Reserve Of Exchange Differences On Translation | |
| Repayments Of Borrowings Classified As Financing Activities | |
| Interest Paid Classified As Financing Activities | |
| Adjustments For Decrease Increase In Inventories | |
| Adjustments For Depreciation And Amortisation Expense | |
| Issue Of Share Capital | $4.6M |
| Reclassification Adjustments On Exchange Differences On Translation Net Of Tax | |
| Share To Be Issued Amount |
Most recent annual filing with the SEC: December 29, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.